Patents by Inventor Jutta Hansen

Jutta Hansen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inhibitors of retroviral proteases
    Patent number: 5712417
    Abstract: The present invention relates to compounds of the formula I ##STR1## wherein A, Y, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, l, m and the corresponding radicals labeled with * are defined as stated in the description, a process for their preparation and their use for the inhibition of retroviral proteases.
    Type: Grant
    Filed: July 11, 1994
    Date of Patent: January 27, 1998
    Assignee: Abbott Laboratories
    Inventors: Karl-Heinz Budt, Bernd Stowasser, Dieter Ruppert, Christoph Meichsner, Arnold Paessens, Jutta Hansen, Jochen Knolle
  • Pseudopeptides with antiviral activity
    Patent number: 5646121
    Abstract: The present invention relates to novel pseudopeptides with antiviral activity of the general formula (I) ##STR1## in which the substituents have the meaning given in the description, to a process for their preparation, and to their use as antiviral agents, especially against cytomegaloviruses.
    Type: Grant
    Filed: September 7, 1994
    Date of Patent: July 8, 1997
    Assignee: Bayer Aktiengesellschaft
    Inventors: Dieter Habich, Thomas-J. Schulze, Jurgen Reefschlager, Jutta Hansen, Rainer Neumann, Gert Streissle, Arnold Paessens
  • Valine-containing pseudopeptides with antiviral activity
    Patent number: 5633231
    Abstract: The present invention relates to valine-containing, substituted pseudopeptides of the general formula (I) ##STR1## in which the substituents have the meaning given in the description, to processes for their preparation, and to their use as anti-viral agents, in particular against cytomegaloviruses.
    Type: Grant
    Filed: September 7, 1994
    Date of Patent: May 27, 1997
    Assignee: Bayer Aktiengesellschaft
    Inventors: Dieter Habich, Thomas J. Schulze, Jurgen Reefschlager, Jutta Hansen, Rainer Neumann, Gert Streissle, Arnold Paessens
  • Trifluoromethyl-containing pseudopeptides active against retroviruses
    Patent number: 5605926
    Abstract: The present invention relates to new trifluoromethyl-containing pseudopeptides of the general formula (I) ##STR1## in which W, A, B, D, E, R.sub.1, R.sub.2 and R.sub.3 have the meaning as outlined of their making and use as pharmaceuticals.
    Type: Grant
    Filed: April 10, 1995
    Date of Patent: February 25, 1997
    Assignee: Bayer Aktiengesellschaft
    Inventors: Dieter H abich, Wolfgang R oben, Jutta Hansen, Arnold Paessens
  • Substituted (2-oxo-1-benzimidazolinyl)-peperidines, process for their preparation, and use as anti-retroviral agents
    Patent number: 5571921
    Abstract: The present invention relates to substituted (2-oxo-1-benzimidazolinyl)-piperidines of the general formula (I) ##STR1## in which the substituents have the meaning indicated in the description, to processes for their preparation and to their use as antiretroviral agents.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: November 5, 1996
    Assignee: Bayer Aktiengesellschaft
    Inventors: Wolfgang Bender, Dieter H abich, Siegfried Raddatz, Wolfgang R oben, Hanno Wild, Jutta Hansen, Arnold Paessens
  • Pseudopeptides having an antiviral action
    Patent number: 5492896
    Abstract: The invention relates to new pseudopeptides having an antiviral action, oft he general formula (I) ##STR1## with the meanings given in the description for the substituents, to a process for their preparation and to their use as antiviral agents, in particular against cytomegaloviruses.
    Type: Grant
    Filed: February 15, 1994
    Date of Patent: February 20, 1996
    Assignee: Bayer Aktiengesellschaft
    Inventors: Dieter Habich, Michael Matzke, Klaus Frobel, Thomas Henkel, Hartwig Muller, Karl-Heinz Weber, Jurgen Reefschlager, Gert Streissle, Jutta Hansen, Rainer Neumann, Arnold Paessens
  • Use of substituted chromans, some of which are known, as medicaments, new active compounds and processes for their preparation
    Patent number: 5492918
    Abstract: The present invention relates to the use of substituted chromans of the general formula (I) ##STR1## in which the substituents have the meaning indicated in the description, for the production of medicaments, in particular as HIV protease-inhibiting agents, new active compounds and processes for their preparation.
    Type: Grant
    Filed: June 1, 1994
    Date of Patent: February 20, 1996
    Assignee: Bayer Aktiengesellschaft
    Inventors: Hanno Wild, Wolfgang Bender, Dieter Habich, Hans-Georg Heine, Siegfried Raddatz, Wolfgang Roben, Jutta Hansen, Arnold Paessens
  • 5-oxo-dibenzo[a,d]cyclohepta-1,4-dienes
    Patent number: 5457108
    Abstract: The invention relates to substituted 5-oxo-di-benzo[a,d]cyclohepta-1,4-dienes of the formula (I) ##STR1## processes for their preparation and their use as retroviral agents.
    Type: Grant
    Filed: September 17, 1993
    Date of Patent: October 10, 1995
    Assignee: Bayer Aktiengesellschaft
    Inventors: Hanno Wild, Jutta Hansen, Jorg Lautz, Arnold Paessens
  • Trifluoromethyl-containing pseudopeptides active against retroviruses
    Patent number: 5430151
    Abstract: The present invention relates to new trifluoromethyl-containing pseudopeptides of the general formula (I) ##STR1## in which W, A, B, D, E, R.sub.1, R.sub.2 and R.sub.3 have the meaning as outlined of their making and use as pharmaceuticals.
    Type: Grant
    Filed: July 24, 1992
    Date of Patent: July 4, 1995
    Assignee: Bayer Aktiengesellschaft
    Inventors: Dieter Habich, Wolfgang Roben, Jutta Hansen, Arnold Paessens
  • Dithiolanylglycine-containing HIV protease inhibitors of the hydroxyethylene isostere type
    Patent number: 5424426
    Abstract: The invention relates to dithiolanylglycine-containing HIV protease inhibitors of the hydroxyethylene isostere type of the general formula (I) ##STR1## processes for their preparation and their use as retroviral agents.
    Type: Grant
    Filed: May 10, 1993
    Date of Patent: June 13, 1995
    Assignee: Bayer Aktiengesellschaft
    Inventors: Dieter Habich, Wolfgang Bender, Jutta Hansen, Arnold Paessens
  • Phosphonate-containing pseudopeptides of the hydroxyethylamine and norstatin type
    Patent number: 5364931
    Abstract: The invention relates to phosphonate-containing pseudopeptides of the hydroxyethylamine and norstatin type, to new oxirane- and thiirane-containing pseudopeptides as intermediates, to processes for their preparation and to their use as retroviral agents.
    Type: Grant
    Filed: August 15, 1991
    Date of Patent: November 15, 1994
    Assignee: Bayer Aktiengesellschaft
    Inventors: Dieter Habich, Jutta Hansen, Arnold Paessens
  • Antiviral new peptides
    Patent number: 5162538
    Abstract: Antiviral new peptides of the formula ##STR1## in which R.sup.3 denotes straight-chain or branched alkyl having up to 8 carbon atoms ordenotes aryl having 6 to 10 carbon atoms or tolyl, andR.sup.4 denotes straight-chain or branched alkyl having up to 8 carbon atoms,and physiologically acceptable salts thereof.
    Type: Grant
    Filed: December 7, 1990
    Date of Patent: November 10, 1992
    Assignee: Bayer Aktiengesellschaft
    Inventors: Klaus-Peter Voges, Dieter Habich, Jutta Hansen, Arnold Paessens, Christoph Meichsner
  • Phosphonopyrrolidine- and piperidine-containing pseudopeptides of the statin type, a process for their preparation and their use as medicaments against retroviruses
    Patent number: 5147865
    Abstract: The invention relates to new phosphonopyrrolidine- and piperidine-containing pseudopeptides, to a process for their preparation and to their use as medicaments, in particular as antiviral agents in human and veterinary medicine.
    Type: Grant
    Filed: August 15, 1991
    Date of Patent: September 15, 1992
    Assignee: Bayer Aktiengesellschaft
    Inventors: Dieter Habich, Jutta Hansen, Arnold Paessens
  • Peptides retroviral protease inhibitors comprising 2-amino-2-methylpropionic acid
    Patent number: 5145951
    Abstract: Antiviral peptides of the formula ##STR1## in which W is an amino protecting group,A,B,D,E and L each independently is a direct bond, or a radical of the formula ##STR2## R.sup.1 and R.sup.2 each independently is cycloakyl or optionally substituted alkyl or alkenyl,Y is --NHR.sup.10, andR.sup.10 is cycloalkyl or optionally substituted alkyl, and their physiologically acceptable salts.The formula includes a 2-amino-2-methylpropionic acid (AiB) residue, which may optionally be protected, as the N-terminal .alpha.-amino acid. The peptides are expected to be useful as medicaments, in particular as antiviral agents in human and veterinary medicine. The peptides are shown to inhibit aspartyl proteases including human immunodeficiency virus (HIV) protease, to have anti-HIV activity and to inhibit the proliferation of HIV in HIV-I infected human lymphocytes. The peptides are expected to be useful in treating patients having HIV related disorders such as ARC and AIDS.
    Type: Grant
    Filed: January 10, 1991
    Date of Patent: September 8, 1992
    Inventors: Klaus-Peter Voges, Dieter Habich, Jutta Hansen, Arnold Paessens